2020 Annual Public Meeting
Each year, the Foundation conducts an Annual Public Board of Directors Meeting to share its activities in support of the U.S. Food and Drug Administration.
Stephen M. Hahn, MD
Commissioner of Food and Drugs
Amy Abernethy, MD, PhD
Principal Deputy Commissioner
Anand Shah, MD
Deputy Commissioner for Medical and Scientific Affairs
Frank Yiannas
Deputy Commissioner for Food Policy and Response
From Anomaly to Precedent: How our COVID-19 response shapes the future of public health
October 13, 2020
12 NOON – 2 PM (Eastern)
The Reagan-Udall Foundation for the FDA’s 2020 Annual Public Meeting will feature top FDA leadership discussing how we responded to the COVID-19 global pandemic, what we learned from that experience, and how it shapes the future of public health. The meeting will be held virtually (a link will be sent to you upon completed registration). The Annual Public Meeting is free and open to the public.
Our Agenda
12:00 pm
|
Welcome & Opening RemarksEllen Sigal, PhD |
---|---|
12:15 pm
|
Panel Discussion
|
1:00 pm |
Commissioner’s Remarks with Q&AStephen M. Hahn, MD |
1:30 pm
|
Public CommentOpen to individuals who have submitted a written request (in advance) to present a three-minute statement. |
2:00 pm |
Adjourn |
*Public comments are strictly limited to three minutes per speaker. Comments should be submitted to Ngozi Amaechi via email at namaechi@reaganudall.org by 5 pm (eastern) on October 9, 2020. The email should include your written comments along with your name, affiliation, address, telephone number, and email address. You will be notified about your request to speak by October 12, 2020.